The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE(−/−) Mice

Background. Our study aimed to observe the effect of sodium glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin on diabetic atherosclerosis and investigate the subsequent mechanism. Methods. Aortic atherosclerosis was induced in streptozotocin induced diabetic ApoE(−/−) mice by feeding with high...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mediators Inflamm
Hlavní autoři: Leng, Weiling, Ouyang, Xinshou, Lei, Xiaotian, Wu, Mingxia, Chen, Liu, Wu, Qinan, Deng, Wuquan, Liang, Ziwen
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5220517/
https://ncbi.nlm.nih.gov/pubmed/28104929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6305735
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky